Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Checking The Pulse - Recent Legal Developments In The Indian Healthcare And Pharma Sector

    In the past couple of months, India's healthcare and pharmaceutical sectors have undergone a series of structural reforms and policy adjustments, highlighting a clear focus on enhancing patient-centricity, strengthening quality standards, and streamlining regulatory compliance.
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Checking The Pulse – Recent Legal Developments In The Indian Healthcare And Pharma Sector

    In the past couple of months, India's healthcare and pharmaceutical sectors have seen a continued push towards regulatory strengthening, quality standardisation, and innovation-driven growth.
    IndiaFood, Drugs, Healthcare, Life Sciences
CMS INDUSLAW
CMS INDUSLAW
  • Article

    Indian Pharmaceutical Companies: Abbreviated New Drug Application Approvals 2017

    The United States Food and Drug Administration (USFDA) approved more Abbreviated New Drug Application (ANDA) in 2017 than any other year, according to its latest FY 2017 activities report.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    GST Council Recommends A Reduction In GST Rates On Essential Goods Being Used For COVID-19 Relief And Management

    In the 43rd GST Council meeting held on 28 May 2021, the Council had decided to constitute a Group of Ministers (GoM) to delve into the need to provide further tax relief by reducing GST rates...
    IndiaTax
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Nano Pharmaceuticals Patents In India: New Hope For Targeted Drug Delivery

    "Nanotechnology" refers to the design, production, or modification of structures, devices, or systems at the nanoscale that is less than 100 nm. Human creativity in nanotechnology dates back to ancient times
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Patent Term Extension In Different Countries

    They are also open to patent term adjustments and corrections too.
    GlobalIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Life Sciences And Healthcare Newsletter | March 2026

    The life sciences and healthcare industry in India continues to evolve through regulatory and policy developments. In March 2026, key developments included proposed frameworks for post-approval...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Medical Device And Healthcare Year-End Wrap [Part II]: Setting The Stage For An Eventful 2020

    While there has been some significant development in the healthcare sector (specifically in the area of regulating doctors), medical devices sector has clearly witnessed the largest number of developments this year.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    USPTO Streamlined Claim Set Pilot Program: A Strategic Pathway To Accelerated Patent Examination

    Patent pendency remains one of the most significant challenges in U.S. patent prosecution. Average first-action wait times range from approximately 20 to 29 months across Technology Centers, creating real costs for startups seeking investor credibility, life sciences companies racing toward product launches, and technology firms defending competitive market position.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Lifesciences And Healthcare Newsletter August 2024

    Welcome to the August 2024 edition of our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    A Critical Study Of Medical Negligence In India, Regulations And Case Laws

    "Medical negligence" is a term commonly used to describe the wrongful actions or omissions of healthcare professionals in the course of their practice, which can result in harm to patients...
    IndiaLitigation, Mediation & Arbitration
    Samisti Legal
    Samisti Legal
  • Article

    GST On Medicines In India: Tax Rates & HSN Codes

    Learn about GST rates on medicines in India, from 0% to 12%, covering essential drugs, Ayurvedic treatments, and their impact on pricing and the healthcare sector.
    IndiaTax
    Vakilsearch
    Vakilsearch
  • Article

    European Medicines Agency's - Human Medicines: Highlights Of 2017

    On January 23, 2018, the European Medicines Agency (EMA) has published its annual report titled ‘Human medicines: Highlights of 201741.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Life Sciences And Healthcare Newsletter | July 2026

    India's life sciences regulatory landscape in July 2026 saw major developments across pharmaceuticals, medical devices, and healthcare regulation. Key changes included the draft National Pharmacy Commission Bill proposing to replace the 80-year-old Pharmacy Act, CDSCO's final guidance on Medical Device Software establishing clear market access pathways, and stricter controls on high-alcohol oral formulations under Schedule H1.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Grants For Research & Development And Innovation In India: Part 1

    Research and Development is the process in which a company or individual develop and innovate new products and services. R&D is widely linked with innovation.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Biotechnology Laws in India

    Biotechnology involves the modification of the basic genetic material in living things namely DNA , which imparts new properties and capabilities in organisms including plants, animals and micro organisms which can be harnessed for a number of useful applications.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dubey & Partners - Advocates
    Dubey & Partners - Advocates
  • Article

    Monthly Life Sciences And Healthcare Newsletter

    Welcome to our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry. This month, we explore a range of significant legal and regulatory updates.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Knee Implants Go Under Scapel Of Price Control In India

    After the recent move to fix the price of the coronary stents, the Indian government has imposed a price ceiling on knee replacement systems for a period of one year by way of a notification dated August 17, 2017.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    NPPA Updates For The Month Of November 2018

    The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Can Biotech Belie The Malthusian Fear?

    The term " green revolution" in India was coined about 35 years ago, which symbolizes the increase in production potential of green plants. This revolution was well supported by the Indian Agricultural Research Scientist and of course the Government Policies. As we are already in the 21st century, we need to produce more grains and other agricultural commodities under conditions of shrinking per capita arable land and irrigation otherwise the Malthusian fear of an imbalance between human nu
    IndiaEmployment and HR
    ICAR
    ICAR
  • Showing 421–440 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics